MedTrace Logo

Retrospective Analysis of Prismaflex HF20 Set Versus ppCRRT Registry

NCT06633029 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 59

Last updated 2026-02-17

No results posted yet for this study

Summary

A retrospective multicenter, observational design intended to capture data on pediatrics (weighing between 8 - 20 kg) who underwent continuous renal replacement therapy (CRRT) using the HF20 set. Data will be compared with a similar population (weighting 8-20 kg) from the ppCRRT registry who received CRRT with Prismaflex M60 sets.

Conditions

  • Acute Renal Failure (ARF)
  • Acute Kidney Injury (AKI)
  • Fluid Overload in Dialysis Patients

Interventions

DEVICE

Prismaflex HF20

CRRT fluid management and reduction of uremic toxins.

Sponsors & Collaborators

  • Baxter Healthcare Corporation

    collaborator INDUSTRY

  • Vantive Health LLC

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-11
Primary Completion
2025-06-25
Completion
2025-06-25
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06633029 on ClinicalTrials.gov